suMMARY Left ventricular pressure, cardiac output, coronary sinus blood flow, and myocardial substrate extraction were measured in 10 patients with congestive (dilated) cardiomyopathy and in a control group of nine patients investigated for chest pain who proved to have no angiographic or metabolic evidence of ischaemic heart disease. Haemodynamic and angiographic measurements confirmed that the patients with cardiomyopathy had severe left ventricular disease. Coronary sinus blood flow and myocardial oxygen consumption were greater in the patients with cardiomyopathy, but were similar in the two groups when normalised for ventricular mass. Efficiency, estimated from the oxygen cost of external work, was grossly reduced in the cardiomyopathy group. No major differences in substrate extraction were demonstrated between the groups. Myocardial lactate production was not observed in any patient with cardiomyopathy. Free fatty acid and glycerol release were observed in several control subjects but in none of the patients with cardiomyopathy.
Congestive, or dilated, cardiomyopathy is a descriptive diagnosis attached to those patients with a primary disorder of cardiac muscle which results in ventricular dilatation, little if any hypertrophy, and reduced ejection.' 2 Investigation rarely yields the aetiology, and microscopical examination of endomyocardial biopsy specimens usually demonstrates non-specific muscle damage.34 Microchemical analysis of biopsy material has shown conspicuously raised levels of cytosol lactate dehydrogenase,5 though this is not a specific marker for the disease, as moderately increased concentrations are found in patients with poor ventricular function secondary to valvular disease. 5 The significance of this finding is uncertain, but because there have been occasional reports of myocardial lactate production in congestive carAccepted for publication 9 October 1981 diomyopathy67 it has been suggested that the increased lactate dehydrogenase levels reflect the importance of anaerobic carbohydrate metabolism as an energy source for the myopathic heart. 5 We have measured haemodynamics, coronary blood flow, and myocardial substrate extraction in 10 patients with severe congestive cardiomyopathy, and in a control group of nine patients investigated for chest pain in whom no cardiac abnormality was found. This study was undertaken to investigate the relation between cardiac work and energy consumption and to identify any abnormality of substrate extraction by the myopathic heart.
Patients and methods
Two groups of patients were studied; 10 patients who had clinical evidence of heart failure thought to result from congestive cardiomyopathy, and nine patients without heart failure who were under investigation for disabling chest pain. The procedure was approved by the hospital ethical committee, and each patient gave written consent.
All studies were performed in the morning after an overnight fast. Digoxin and diuretics were continued in the cardiomyopathy group until the time of study, but in the chest pain group beta-blocking drugs were stopped 48 hours beforehand. Premedication was with atropine 0*3 mg and diazepam 10 mg intramuscularly. At the same time heparin (45 units/kg) was given intravenously to minimise the effect of a subsequent dose of heparin upon free fatty acid concentrations. 8 (Tables 1 and 2 ) Basal heart rate was 99 + 8 beats/min in the patients with cardiomyopathy and 86 _ 6 beats/min in the control subjects (NS). Cardiac index, left ventricular systolic pressure, minute work, max dP/dt, KVmax, and ejection fraction were significantly lower, and end-diastolic volume index and end-diastolic pressure signifcantly higher in the cardiomyopathy group than in the controls. Coronary sinus blood flow and myocardial oxygen consumption were increased in the patients with cardiomyopathy compared with the control subjects and, as their left ventricular minute work was low, calculated efficiency was grossly reduced. None of the patients with cardiomyopathy had severe hypertrophy, though end-diastolic left ventricular free wall thickness, 0-93 + 0-06 cm, was greater than in the control subjects, 0-69 + 0-04 cm (p<005). Because of this small increase in wall thickness and the large increases in cavity dimensions, left ventricular mass was significantly greater in the cardiomyopathy than in the control group. Coronary sinus blood flow and myocardial oxygen consumption normalised for ventricular mass were similar in the two groups. The arterial and coronary venous concentrations, extraction, extraction ratio, and oxygen extraction ratio of the six substrates measured are listed in Table  3 .
The high mean arterial lactate concentration in the cardiomyopathy group was largely the result of concentrations of 2*705 and 1*379 mmol/l in cases 3 and 8, both of whom had a very low cardiac output. Myocardial lactate production was not observed in either group. Though lactate extraction and oxygen extraction ratio were significantly greater in the cardiomyopathy than in the control group, these differences were caused in part by greater arterial lactate concentrations. Extraction ratio did not differ significantly between the two groups.
No differences were shown,between the two groups in concentrations or extraction of pyruvate, hydroxybutyrate, or acetoacetate.
Free fatty acid extraction was positive in each of the patients with cardiomyopathy, whereas two of the control subjects had negative values. Extraction and extraction ratio were significantly greater in the cardiomyopathy than in the control group and these differences were still significant when the two controls with negative values were excluded from analysis.
Glycerol extraction was positive in each of the six patients with cardiomyopathy, but glycerol release was observed in six of the nine control subjects; consequently glycerol extraction and extraction ratio were significantly greater in the cardiomyopathy group. The efficiency of the heart can be estimated by relating external work to myocardial oxygen consumption.'9 The mean value of 39% in the control group is in close agreement with previous estimates of the efficiency of the normal heart.'9 Each of the patients with cardiomyopathy had low efficiency, and their mean value of 4% emphasises the severity of the disturbance of myocardial energetics. The oxygen consumption of the ventricle is determined largely by muscle tension,20 dependent upon both pressure and volume, while external work is determined by the extent of muscle shortening against this tension (load). Dilatation therefore increases both myocardial oxygen consumption and the load opposing shortening. When muscle function is poor, shortening against load is reduced, so efficiency will be low, and will decrease further as energy consumption and load increase with further dilatation. That the failing dilated heart operates against excessive load is suggested by the large improvement in efficiency during infusion of sodium nitroprusside.21 Dilatation and excessive load are logical consequences of poor contractile function, and efficiency may be low when oxidative metabolism and the oxygen cost of tension development are normal.
The normal ventricle hypertrophies without dilating in response to chronic pressure overload, and the increased wall thickness maintains wall stress within normal limits.22 When a ventricle of a given mass dilates, the increase in cavity dimensions and decreased wall thickness will increase stress, which may stimulate hypertrophy. Though none of our patients had gross hypertrophy, their end-diastolic wall thickness was greater than in the control subjects and their greater myocardial oxygen consumption was related largely to increased mass.
The normal heart derives its energy supply from the oxidation of free fatty acids, lactate, and glucose, with smaller contributions from the oxidation of pyruvate and ketone bodies. 23 The pattern of substrate extraction in both groups of patients was broadly similar to results reported for the normal heart.2325
Myocardial lactate extraction was high in each of the patients with cardiomyopathy, and myocardial lactate production was not observed in either group. Lactate extraction and oxygen extraction ratio were significantly greater in the cardiomyopathy group than in controls. These differences may have been the result in part of the high arterial lactate concentrations observed in several patients in the cardiomyopathy group. In addition, the high arterial free fatty acid concentrations in several control subjects would be expected to inhibit myocardial lactate extraction. There have been occasional reports of lactate production by the myopathic heart,6 7 and it has been suggested that anaerobic carbohydrate metabolism is an important energy source in this condition.5 As myocardial lactate production was not observed in our patients it is unlikely that anaerobic metabolism contributed significantly to energy requirements, or that ischaemia was responsible for poor contractile function.
The study of myocardial free fatty acid metabolism is complicated by the activation of lipoprotein lipase by heparin. 28 We believe that adequate anticoagulation is mandatory for left heart catheterisation, and all patients in this study received heparin. In a previous study we showed that intravenous heparin administered one hour before catheterisation effectively attenuates the rise in arterial free fatty acids after a subsequent dose of heparin, and that within 30 minutes of this second dose, given at the time of arterial catheterisation, arterial concentration returns to control levels.8 This regimen of two doses was used in this study.
Experiments with labelled palmitate have shown that in the normal heart there is myocardial lipolysis with release of free fatty acids into coronary venous blood.29 Free fatty acids extracted by the heart may be esterified rather than oxidised immediately,30 and free fatty acids derived from lipolysis may be oxidised.30 Thus, measured extraction may not reflect true uptake, and true uptake, if it were known, does not measure the rate of oxidation. In addition, when the arteriovenous concentration difference is narrow, small errors in measuring concentrations will have a large effect upon estimated extraction. For these reasons the finding of significantly greater free fatty acid extraction and extraction ratio in the cardiomyopathy compared with the control group should be viewed with caution.
Despite these difficulties it is of great interest that release of neither free fatty acids nor glycerol was observed in the patients with cardiomyopathy, whereas free fatty acid release was found in two, and glycerol release in six of the nine control subjects. Release of free fatty acids and glycerol are also common in patients with coronary artery disease8 31 and hypertrophic obstructive cardiomyopathy.27 It cannot be concluded from this study that free fatty acid metabolism is abnormal in congestive cardiomyopathy, but this problem merits further investigation with labelled free fatty acids.
Because patients with congestive cardiomyopathy improve clinically during long-term administration of beta-blocking drugs3233 and relapse when they are withdrawn,34 catecholamine excess or sympathetic overactivity have been suggested as pathogenic mechanisms.33 34 Acutely catecholamines increase myocardial lipolysis35 and the arterial concentration and myocardial oxidation of free fatty acids,36 and inhibit pyruvate dehydrogenase.37 The relatively low arterial free fatty acid concentrations, the absence of glycerol release, and the consistently high lactate extraction ratios in our patients do not suggest catecholamine excess. It is unlikely that the beneficial effect of beta-blocking drugs is the result either of changes in myocardial substrate extraction or relief of ischaemia.
In the control group the haemodynamic changes during pacing were normal,3839 whereas in the five patients with cardiomyopathy who were paced, enddiastolic pressure tended to rise and indices of contractility did not increase significantly. Coronary sinus blood flow increased substantially with heart rate in each control subject, but in only one patient with cardiomyopathy. Failure to increase flow with heart rate implies that the coronary vasculature is near maximal dilatation at rest. Under these circumstances coronary flow is critically dependent upon cardiac output and the length of diastole; in both of the patients who sustained reductions of coronary flow cardiac output decreased on pacing. Failure to augment coronary flow as heart rate increases in patients with severe aortic stenosis40 or hypertrophic obstructive cardiomyopathy27 is associated with myocardial lactate production. Lactate extraction remained high in each of our five patients. Thus, the myopathic heart does not resort to anaerobic metabolism even during the stress of pacing.
This study shows that the overall efficiency of the heart is severely reduced in congestive cardiomyopathy. Though there were small differences in substrate extraction between the two groups, no gross abnormality of oxidative metabolism was found in patients with congestive cardiomyopathy, suggesting that low efficiency lies in poor mechanical function rather than in deficient energy supply. 
